Date 23/apr/2023 12:20PM Unit Bio Ref Interval: Kindly Correlate With Clinical Findings

Laboratory Investigation Report
Patient Name : Mrs. Anjana Chawla Centre : 3924 - Max Lab Jagadhri Road, Ambala
Age/Gender : 60 Y 0 M 0 D /F OP/IP No/UHID : //
MaxID/Lab ID : ML03748779/3703042300077 Collection Date/Time : 23/Apr/2023 12:20PM
Ref Doctor : SELF Reporting Date/Time : 23/Apr/2023 03:33PM
Clinical Biochemistry
SIN No:B2B3247852
Blood Sugar - Post Prandial (Glucose PP), 2 Hrs, Fluoride Plasma

Date 23/Apr/2023 Unit Bio Ref Interval
12:20PM
Glucose PP 76 mg/dL 100 - 140
Kindly correlate with clinical findings
*** End Of Report ***
Page 1 of 14
Test Performed at :1066 - Max Hospital Mohali, Near Civil Hospital, Phase-6,Mohali
Booking Centre :3924 - Max Lab Jagadhri Road, Ambala, SN/13, Near MC Office Jagadhari Road, Ambala Cantt, 8813043495
The authenticity of the report can be verified by scanning the Q R Code on top of the page
Hematology
SIN No:B2B3247852
Wellwise Total Profile
Complete Haemogram, Peripheral Smear and ESR,EDTA

12:20PM
Haemoglobin 10.7 g/dl 12.0 - 15.0
Modified cyanmethemoglobin
Packed Cell, Volume 33.9 % 40-50
Calculated
Total Leucocyte Count (TLC) 4.8 10~9/L 4.0-10.0
Electrical Impedance
RBC Count 3.39 10~12/L 3.8-4.8
MCV 100.1 fL 83-101
MCH 31.5 pg 27-32
Calculated
MCHC 31.5 g/dl 31.5-34.5
Calculated
Platelet Count 186 10~9/L 150-410
MPV 10.6 fl 7.8-11.2
Calculated
RDW 14.8 % 11.5-14.5
Calculated
Differential Cell Count

VCS / Light Microscopy
Neutrophils 38.3 % 40-80

Lymphocytes 47.7 % 20-40
Monocytes 7.8 % 2-10
Eosinophils 4.9 % 1-6
Basophils 1.3 % 0-2
Absolute Leukocyte Count

Calculated from TLC & DLC
Absolute Neutrophil Count 1.84 10~9/L 2.0-7.0

Absolute Lymphocyte Count 2.3 10~9/L 1.0-3.0
Absolute Monocyte Count 0.37 10~9/L 0.2-1.0
Absolute Eosinophil Count 0.24 10~9/L 0.02-0.5
Absolute Basophil Count 0.06 10~9/L 0.02-0.1
ESR (Westergren) 75 mm/hr <=19
Page 2 of 14
Hematology
SIN No:B2B3247852
Peripheral Smear
Examination
RBC: - Normocytic Normochromic
WBC: - Series show mild relative lymphocytosis
Platelet: - Adequate
Page 3 of 14
SIN No:B2B3247852
Fasting Blood Sugar (Glucose) , (FBS), Fluoride Plasma

12:20PM
Glucose (Fasting) 78 mg/dL 74 - 99
HbA1c (Glycated/ Glycosylated Hemoglobin) Test

HPLC
Date 23/Apr/2023 Unit Bio Ref

12:20PM Interval
Glycosylated 6.0 % < 5.7
Haemoglobin(Hb A1c)
Glycosylated 42.06 mmol/mol < 39.0
Haemoglobin(Hb A1c) IFCC
Average Glucose Value For 125.5 mg/dL
the Last 3 Months
Average Glucose Value For 6.95 mmol/L
the Last 3 Months IFCC
Interpretation The following HbA1c ranges recommended by the American Diabetes Assocation(ADA) may be used as an aid in the diagnosis of diabetes
mellitus.
HbA1C(NGSP %) HbA1C(IFCC mmol/mol) Suggested Diagnosis

> 6.5 > 48 Diabetic
5.7 - 6.4 39 - 47 Pre- Diabetic
< 5.7 < 39 Non - Diabetic
HbA1C provides a useful index of average glycaemia over the preceding 6-8 weeks.
It is suggested that HbA1c is measured every 6 months in stable patients, every 3 months in patients with unstable metabolic control and every month in pregnancy.
Increased Glycated hemoglobin is a reflection of Hyperglycemia.
Page 4 of 14
SIN No:B2B3247852
Page 5 of 14
Immunoassay
SIN No:B2B3247852
Thyroid Profile*,Serum
12:20PM Interval
Free Triiodothyronine (FT3) 2.38 pg/mL 2.6 - 4.2
CLIA
Free Thyroxine (FT4) 1.02 ng/dL 0.58 - 1.64
CLIA
Thyroid Stimulating 14.056 µIU/mL 0.34 - 5.6
Hormone
CLIA
Comment
Premature Cord Blood
Upto 2 1st 2nd 3rd
Parameter Unit (28 - 36 (> 37 Adult
Month Trimester Trimester Trimester
weeks) weeks)
FT3 Pg/mL 0.15 - 3.91 2.4 - 5.6 2.6 - 4.2 2.11 - 3.83 1.96 - 3.38 1.96 - 3.38
TSH uIU/ml 0.7 - 27.0 2.3 - 13.2 0.5 - 10 0.38 - 5.33 0.1 - 2.5 0.2 - 3.0 0.3 - 3.0
Note : TSH levels are subject to circadian variation, reaching peak levels between 2 – 4 am
and at a minimum between 6 – 10 pm. The variation is of the order of 50% - 206 %, hence
time of the day has influence on the measured serum TSH concentrations.
Page 6 of 14
SIN No:B2B3247852
Kidney Function Test (KFT) Profile with Calcium, Uric Acid, Serum
12:20PM Interval
Urea 29.0 mg/dL 17.0 - 43.0
Urease, UV
Blood Urea Nitrogen 13.55 mg/dL 7.9 - 20.0
Urease, UV
Creatinine 0.92 mg/dL 0.6 - 1.1
Alkaline picrate kinetic
eGFR 62.27 ml/min/1.73
MDRD m²
Bun/Creatinine Ratio 14.73 Ratio 12:1 - 20:1
Calculated
Uric Acid 5.4 mg/dL 2.6 - 6.0
Uricase, Colorimetric
Calcium (Total) 9.70 mg/dL 8.8 - 10.6
Arsenazo III
Sodium 141.0 mmol/L 136 - 146
ISE indirect
Potassium 4.25 mmol/L 3.5 - 5.1
ISE indirect
Chloride 105 mmol/L 101 - 109
ISE indirect
Bicarbonate 28.0 mmol/L 21 - 31
Enzymatic
Interpretation Ref. Range

eGFR - Estimated Glomerular Filteration Rate is calculated by MDRD equation which is most accurate for GFRs ≤ 60ml / min /1.73 m².MDRD equation is used for
adult population only.
<60ml / min / 1.73 m² - Chronic Kidney Disease
<15 ml / min /1.73 m² - Kidney failure
BUN/Creatinine Ratio :-
Increased in reduced renal perfusion (e.g. dehydration, Hypovolemic shock, Congestive Heart Failure) or Obstructive uropathy. Decreased in Acute Renal Tubular
necrosis.
Page 7 of 14
SIN No:B2B3247852
Liver Function Test (LFT), Serum

12:20PM
Total Protein 7.38 g/dL 6.6 - 8.3
Biuret
Albumin 4.0 g/dL 3.5 - 5.2
Bromcresol Green (BCG)
Globulin 3.4 g/dl 2.3 - 3.5
Calculated
A.G. ratio 1.2 1.2 - 1.5
Calculated
Bilirubin (Total) 0.69 mg/dL 0.3 - 1.2
DPD
Bilirubin (Direct) 0.14 mg/dL 0.0 - 0.2
Diazotization
Bilirubin (Indirect) 0.55 mg/dL 0.1 - 1.0
Calculated
SGOT- Aspartate 25 U/L < 35
Transaminase (AST)
UV without P5P
SGPT- Alanine 16 U/L < 35
Transaminase (ALT)
UV without P5P
AST/ALT Ratio 1.56 Ratio
Calculated
Alkaline Phosphatase 80 U/L 30 - 120
PNPP, AMP Buffer
GGTP (Gamma GT), Serum 15.0 U/L < 38
G-Glutamyl-Carboxy-Nitroanilide
IFCC
Interpretation AST/ALT Ratio : -

In Case of deranged AST and/or ALT, the AST/ALT ratio is > 2.0 in alcoholic liver damage and < 2.0 in non – alcoholic liver damage
Page 8 of 14
SIN No:B2B3247852
Lipid Profile,Serum
12:20PM Interval
Cholesterol 122 mg/dL < 200
Cholesterol oxidase, esterase,
peroxidase
HDL Cholesterol 42 mg/dL > 40
Direct measure, immunoinhibition
LDL Cholesterol 59 mg/dL < 100
Direct measure
Triglyceride 102.0 mg/dL < 150
Enzymatic, end point
VLDL Cholesterol 20.4 mg/dl < 30
Calculated
Total Cholesterol/HDL Ratio 2.9 .. 0.0-4.9
Calculated
Non-HDL Cholesterol 80.00 mg/dL < 130
Calculated
HDL/LDL 0.71 Ratio 0.3 - 0.4
Calculated
Interpretation
Optimal: < 100 mg/dL

Near Optimal/ Above Optimal: 100-
Desirable: < 200 mg/dL
129
Borderline High: 200-239
Total mg/dL
mg/dL LDL-C
Cholesterol Borderline High: 130-159 mg/dL
High ≥ 240 mg/dL
High: 160-189 mg/dL
Very High: ≥ 190 mg/dL
Normal: <150 mg/dL

Low HDL: < 40 mg/dL Borderline High: 150-199 mg/dL
HDL-C Triglyceride
High HDL: ≥ 60 mg/dL High: 200-499 mg/dL
Very High: ≥ 500 mg/dL
Page 9 of 14
SIN No:B2B3247852
Inorganic Phosphorus, Serum

12:20PM
Phosphorus(inorg) 4.42 mg/dL 2.5 - 4.5
Phosphomolybdate-UV
Interpretation
Increased in Osteolytic metastatic bone tumors, myelogenous leukemia, sarcoidosis, milk-alkali syndrome, vitamin D intoxcation, healing fractures, renal failure,
hyperparathyroidism, PTH resistance (Pseudohypoparathyroidism) and diabetes mellitus with ketosis.
Decreased in Osteomalacia, steatorrhea, renal tubular acidosis, growth hormone deficiency, acute alcoholism, gram-negative bacterial septicemia, hypokalemia, familial
hypophosphatemic rickets, Vitamin D deficiency, severe malnutrition, malabsorption, secondary diarrhea, vomiting, nasogastric suction, primary hyperthyroidism
and PTH producing tumors.
Page 10 of 14
Immunoassay
SIN No:B2B3247852
Vitamin D, 25 - Hydroxy Test (Vit. D3), Serum

12:20PM Interval
25 Hydroxy, Vitamin D 26.02 ng/mL 30-100
CLIA
Ref Range
25 (OH) Vitamin D Concentration Range
Vitamin D Status
(ng/ml)
Sufficiency 30-100
Insufficiency 20-29
Deficiency <20
Potential Toxicity
>100
Interpretation
Vitamin D toxicity can be due to
1. Use of high doses of vitamin D for prophylaxis or treatment
2. Taking vitamin D supplements with existing health problems such as kidney disease, liver disease , tuberculosis and hyperparathyroidism
Vitamin D deficiency can be due to:
1. Inadequate exposure to sunlight,
2. Diet deficient in vitamin D
3. Malabsorption
Advice: Serum calcium, phosphorus and PTH
Page 11 of 14
Immunoassay
SIN No:B2B3247852
Vitamin B12 (Vit- B12), (Cyanocobalamin), Serum

12:20PM
Vitamin B12 <50.0 pg/mL 120 - 914
CLIA
Interpretation
Note:- Vitamin B12 (Cobalamin)
Vitamin B12 is tested for patients with GIT disease, Neurological disease, psychiatric disturbances, malnutrition, alcohol abuse.
Increased in chronic renal failure, severe CHF.
Decreased in megaloblastic anemia.
Advise: CBC, peripheral smear, serum folate levels, intrinsic factor antibodies (IFA), bone marrow examination, if Vit B12 deficient.
Page 12 of 14
Clinical Pathology
SIN No:B2B3247852
Urine Routine And Microscopy

12:20PM
Macroscopy
Colour Pale Yellow Pale Yellow

Visual Observation/ Automated
PH 6.0 .. 5-6
Double Indicator
Specific Gravity 1.010 1.015 - 1.025
pKa change
Protein Nil Nil
Protein-error of indicators
Glucose. Nil Nil
Enzyme Reaction
Ketones Nil Nil
Acetoacetic Reaction
Blood Nil Nil
Benzidine Reaction
Bilirubin Nil Nil
Diazo Reaction
Urobilinogen Normal Normal
Ehrlichs Reaction
Nitrite Negative
Conversion of Nitrate
Microscopy
Red Blood Cells (RBC) Nil /HPF Nil

Light Microscopy/Image capture
microscopy
White Blood Cells Nil /HPF 0.0-5.0
microscopy
Squamous Epithelial Cells 1 /HPF
microscopy
Cast Nil /LPF Nil
microscopy
Crystals Nil .. Nil
microscopy
Page 13 of 14
Clinical Pathology
SIN No:B2B3247852
Bacteria Nil /HPF Nil

microscopy

Page 14 of 14

Date 23/apr/2023 12:20PM Unit Bio Ref Interval: Kindly Correlate With Clinical Findings

Uploaded by

Copyright:

Available Formats

Date 23/apr/2023 12:20PM Unit Bio Ref Interval: Kindly Correlate With Clinical Findings

Uploaded by

Document Information

Original Description:

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Date 23/apr/2023 12:20PM Unit Bio Ref Interval: Kindly Correlate With Clinical Findings

Uploaded by

Copyright:

Available Formats

Laboratory Investigation Report

Blood Sugar - Post Prandial (Glucose PP), 2 Hrs, Fluoride Plasma

Kindly correlate with clinical findings

*** End Of Report ***

Complete Haemogram, Peripheral Smear and ESR,EDTA

Differential Cell Count

Neutrophils 38.3 % 40-80

Absolute Leukocyte Count

Absolute Neutrophil Count 1.84 10~9/L 2.0-7.0

Kindly correlate with clinical findings

*** End Of Report ***

Fasting Blood Sugar (Glucose) , (FBS), Fluoride Plasma

HbA1c (Glycated/ Glycosylated Hemoglobin) Test

Date 23/Apr/2023 Unit Bio Ref

HbA1C(NGSP %) HbA1C(IFCC mmol/mol) Suggested Diagnosis

Kindly correlate with clinical findings

*** End Of Report ***

Kindly correlate with clinical findings

*** End Of Report ***

Interpretation Ref. Range

Liver Function Test (LFT), Serum

Interpretation AST/ALT Ratio : -

Optimal: < 100 mg/dL

Normal: <150 mg/dL

Inorganic Phosphorus, Serum

Kindly correlate with clinical findings

*** End Of Report ***

Vitamin D, 25 - Hydroxy Test (Vit. D3), Serum

Vitamin B12 (Vit- B12), (Cyanocobalamin), Serum

Kindly correlate with clinical findings

*** End Of Report ***

Urine Routine And Microscopy

Colour Pale Yellow Pale Yellow

Red Blood Cells (RBC) Nil /HPF Nil

Bacteria Nil /HPF Nil

Kindly correlate with clinical findings

You might also like

* End Of Report *

* End Of Report *

* End Of Report *

* End Of Report *

* End Of Report *

* End Of Report *